Anthos Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Anthos Therapeutics is a clinical-stage biotechnology company developing therapies for cardiovascular and metabolic diseases, grounded in genetically and pharmacologically validated targets. The company aims to combine the speed and flexibility typical of a biotech with the discipline and rigor of a larger pharmaceutical organization. It is based in Cambridge, Massachusetts, and was founded in 2019 by Blackstone Life Sciences. Its focus is on developing therapies that address cardiovascular and metabolic conditions to improve patient care. Its programs are designed to serve patients living with cardiovascular and metabolic diseases. In late October 2024, the company announced the appointment of Will Kane as president and chief commercial officer.